Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Somlo

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|May 26, 1999
Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin statusL D Curcio, E Rupp, W L Williams, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Phase I trial of interleukin-2 plus gamma-interferonK A Margolin, J H Doroshow, S A Akman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2011
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumorsH K Chew, G Somlo, P C Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanomaK A Margolin, J H Doroshow, S A Akman, et al.
American Journal of Clinical Oncology|April 1, 1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancerK A Margolin, S Green, K Osborne, et al.
Cancer|March 15, 1994
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology TeamG Somlo, J H Doroshow, S J Forman, et al.
Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.
Oncogene|May 3, 2011
FZD7 has a critical role in cell proliferation in triple negative breast cancerL Yang, X Wu, Y Wang, et al.
Cancer|January 1, 1994
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancerG Somlo, J H Doroshow, S J Forman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trialG Somlo, J H Doroshow, A Lev-Ran, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|May 26, 1999
Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin statusL D Curcio, E Rupp, W L Williams, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Phase I trial of interleukin-2 plus gamma-interferonK A Margolin, J H Doroshow, S A Akman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2011
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumorsH K Chew, G Somlo, P C Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanomaK A Margolin, J H Doroshow, S A Akman, et al.
American Journal of Clinical Oncology|April 1, 1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancerK A Margolin, S Green, K Osborne, et al.
Cancer|March 15, 1994
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology TeamG Somlo, J H Doroshow, S J Forman, et al.
Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.
Oncogene|May 3, 2011
FZD7 has a critical role in cell proliferation in triple negative breast cancerL Yang, X Wu, Y Wang, et al.
Cancer|January 1, 1994
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancerG Somlo, J H Doroshow, S J Forman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trialG Somlo, J H Doroshow, A Lev-Ran, et al.
Pageof 7